Related Experiment Video
Updated: Apr 16, 2026

Clinicopathological Analysis of miRNA Expression in Breast Cancer Tissues by Using miRNA In Situ Hybridization
Published on: June 7, 2016
MiRNAs in primary cutaneous lymphomas
1Department of Dermatology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
MicroRNAs (miRNAs) are key regulators in primary cutaneous lymphomas (PCL). This review details miRNA expression and function in PCL subtypes, highlighting their diagnostic and therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Primary cutaneous lymphomas (PCL) are a diverse group of diseases with unclear causes.
- MicroRNAs (miRNAs) are critical regulators of gene expression implicated in PCL development.
- Dysregulated miRNA expression is a common feature in PCL.
Purpose of the Study:
- To review the expression patterns of miRNAs across various PCL subtypes.
- To elucidate the functional roles of miRNAs in the molecular pathogenesis of PCL.
- To explore the potential clinical applications of miRNAs in PCL management.
Main Methods:
- Literature review of studies on miRNA expression and function in PCL.
- Analysis of reported miRNA deregulation in different PCL subtypes.
- Synthesis of experimental data on miRNA roles in PCL carcinogenesis.
Main Results:
- miRNAs are frequently deregulated in PCL.
- Specific miRNAs show distinct expression profiles in different PCL subtypes.
- Functional studies confirm the involvement of miRNAs in PCL pathogenesis.
Conclusions:
- miRNAs play significant roles in the molecular mechanisms underlying PCL.
- Understanding miRNA expression and function is crucial for PCL research.
- miRNAs represent a promising avenue for PCL biomarkers and targeted therapies.
More Related Videos
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Related Concept Videos
MicroRNAs
MicroRNAs
Non-LTR Retrotransposons